• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化细胞外囊泡高效递送GSDMD-N mRNA可诱导细胞焦亡以增强免疫治疗

Efficient Delivery of GSDMD-N mRNA by Engineered Extracellular Vesicles Induces Pyroptosis for Enhanced Immunotherapy.

作者信息

Xing Yuqi, Zhang Feiyu, Ji Panpan, Wei Mengying, Yin Chunhui, Yang Angang, Yang Guodong, Zhao Jing

机构信息

The State Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.

Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.

出版信息

Small. 2023 May;19(20):e2204031. doi: 10.1002/smll.202204031. Epub 2023 Jan 12.

DOI:10.1002/smll.202204031
PMID:36635060
Abstract

Pyroptosis is a newly discovered inflammatory form of programmed cell death, which promotes systemic immune response in cancer immunotherapy. GSDMD is one of the key molecules executing pyroptosis, while therapeutical delivery of GSDMD to tumor cells is of great challenge. In this study, an extracellular vesicles-based GSDMD-N mRNA delivery system (namely EV ) is developed for enhanced cancer immunotherapy, with GSDMD-N mRNA encapsulated inside, Ce6 (Chlorin e6 (Ce6), a hydrophilic sensitizer) incorporated into extracellular vesicular membrane, and HER2 antibody displayed onto the surface. Briefly, GSDMD-N mRNA is translationally repressed in donor cells by optimized puromycin, ensuring the cell viability and facilitating the mRNA encapsulation into extracellular vesicles. When targeted and delivered into HER2 breast cancer cells by the engineered extracellular vesicles, the translational repression is unleashed in the recipient cells as the puromycin is diluted and additionally inactivated by sonodynamic treatment as the extracellular vesicles are armed with Ce6, allowing GSDMD-N translation and pyroptosis induction. In addition, sonodynamic treatment also induces cell death in the recipient cells. In the SKBR3- and HER2 transfected 4T1- inoculated breast tumor mouse models, the engineered EV efficiently induces a powerful tumor immune response and suppressed tumor growth, providing a nanoplatform for cancer immunotherapy.

摘要

细胞焦亡是一种新发现的程序性细胞死亡的炎症形式,在癌症免疫治疗中可促进全身免疫反应。Gasdermin D(GSDMD)是执行细胞焦亡的关键分子之一,而将GSDMD递送至肿瘤细胞进行治疗具有很大挑战。在本研究中,开发了一种基于细胞外囊泡的GSDMD-N mRNA递送系统(即EV)用于增强癌症免疫治疗,其中GSDMD-N mRNA包裹在内部,Ce6(二氢卟吩e6(Ce6),一种亲水性敏化剂)掺入细胞外囊泡膜中,并在表面展示HER2抗体。简而言之,通过优化的嘌呤霉素在供体细胞中抑制GSDMD-N mRNA的翻译,确保细胞活力并促进mRNA包裹到细胞外囊泡中。当通过工程化细胞外囊泡靶向递送至HER2阳性乳腺癌细胞时,随着嘌呤霉素被稀释且细胞外囊泡携带Ce6后通过声动力处理使其额外失活,受体细胞中的翻译抑制被解除,从而允许GSDMD翻译并诱导细胞焦亡。此外,声动力处理还可诱导受体细胞死亡。在SKBR3和HER2转染的4T1接种的乳腺肿瘤小鼠模型中,工程化的EV有效诱导强大的肿瘤免疫反应并抑制肿瘤生长,为癌症免疫治疗提供了一个纳米平台。

相似文献

1
Efficient Delivery of GSDMD-N mRNA by Engineered Extracellular Vesicles Induces Pyroptosis for Enhanced Immunotherapy.工程化细胞外囊泡高效递送GSDMD-N mRNA可诱导细胞焦亡以增强免疫治疗
Small. 2023 May;19(20):e2204031. doi: 10.1002/smll.202204031. Epub 2023 Jan 12.
2
PhospholipaseCγ1/calcium-dependent membranous localization of Gsdmd-N drives endothelial pyroptosis, contributing to lipopolysaccharide-induced fatal outcome.PLCγ1/钙离子依赖的 Gsdmd-N 膜定位驱动内皮细胞焦亡,导致脂多糖诱导的致命结局。
Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1482-H1495. doi: 10.1152/ajpheart.00731.2019. Epub 2020 Oct 16.
3
Pyroptosis executioner gasdermin D contributes to host defense and promotes Th 1 immune response during Neospora caninum infection.焦亡执行者 gasdermin D 有助于宿主防御,并在刚地弓形虫感染期间促进 Th1 免疫应答。
Vet Parasitol. 2020 Oct;286:109254. doi: 10.1016/j.vetpar.2020.109254. Epub 2020 Sep 22.
4
Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway.氢气通过 ROS/NLRP3/caspase-1/GSDMD 介导的细胞焦亡途径抑制子宫内膜癌细胞生长。
BMC Cancer. 2020 Jan 10;20(1):28. doi: 10.1186/s12885-019-6491-6.
5
Mitochondria-targeting sonosensitizer-loaded extracellular vesicles for chemo-sonodynamic therapy.用于化学-声动力疗法的负载线粒体靶向声敏剂的细胞外囊泡
J Control Release. 2023 Feb;354:651-663. doi: 10.1016/j.jconrel.2023.01.044. Epub 2023 Jan 25.
6
A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells by transgenic expression of a truncated GSDMD N-terminus.一种新的基于转导表达截断的 GSDMD N 端诱导肿瘤细胞焦亡的个性化疫苗策略。
Front Immunol. 2022 Sep 15;13:991857. doi: 10.3389/fimmu.2022.991857. eCollection 2022.
7
Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1/CC chemokine receptor-2 to recruit macrophages.Gasdermin D 介导的肝细胞焦亡通过上调单核细胞趋化蛋白 1/CC 趋化因子受体-2 招募巨噬细胞来扩大炎症反应,从而加重急性肝衰竭。
World J Gastroenterol. 2019 Nov 28;25(44):6527-6540. doi: 10.3748/wjg.v25.i44.6527.
8
The role of Caspase-1/GSDMD-mediated pyroptosis in Taxol-induced cell death and a Taxol-resistant phenotype in nasopharyngeal carcinoma regulated by autophagy.Caspase-1/GSDMD 介导的细胞焦亡在紫杉醇诱导的鼻咽癌细胞死亡和自噬调控的紫杉醇耐药表型中的作用。
Cell Biol Toxicol. 2020 Oct;36(5):437-457. doi: 10.1007/s10565-020-09514-8. Epub 2020 Jan 28.
9
[Extracellular histones aggravate acute respiratory distress syndrome by inducing peripheral blood mononuclear cells pyroptosis].[细胞外组蛋白通过诱导外周血单个核细胞焦亡加重急性呼吸窘迫综合征]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Nov;31(11):1357-1362. doi: 10.3760/cma.j.issn.2095-4352.2019.11.009.
10
Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis.狼疮肾炎中 caspase-1/Gasdermin D 诱导的细胞焦亡途径抑制的联合治疗新作用。
Front Immunol. 2021 Nov 19;12:720877. doi: 10.3389/fimmu.2021.720877. eCollection 2021.

引用本文的文献

1
Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis.乳腺癌新型细胞死亡机制的研究进展:铁死亡、铜死亡、二硫死亡和焦亡的交叉视角
Mol Cancer. 2025 Aug 27;24(1):224. doi: 10.1186/s12943-025-02445-0.
2
Sonodynamic biomimetic-nanomedicine fight cancers.声动力仿生纳米药物对抗癌症。
J Nanobiotechnology. 2025 Jul 30;23(1):548. doi: 10.1186/s12951-025-03583-9.
3
Deletion of gasdermin D promotes granulocytic myeloid-derived suppressor cell differentiation by decreased release of mitochondrial DNA to promote tumor escape.
gasdermin D的缺失通过减少线粒体DNA的释放促进粒细胞髓系来源的抑制性细胞分化,从而促进肿瘤逃逸。
Cancer Immunol Immunother. 2025 Jul 25;74(9):277. doi: 10.1007/s00262-025-04104-1.
4
Nanomedicine-induced pyroptosis for anti-tumor immunotherapy: Mechanism analysis and application prospects.纳米医学诱导的焦亡用于抗肿瘤免疫治疗:机制分析与应用前景
Acta Pharm Sin B. 2025 Jul;15(7):3487-3510. doi: 10.1016/j.apsb.2025.05.021. Epub 2025 May 26.
5
GSDMD is a novel predictive biomarker for immunotherapy response: in the pan-cancer and single cell landscapes.Gasdermin D是免疫治疗反应的一种新型预测生物标志物:在泛癌和单细胞领域。
Front Immunol. 2025 May 26;16:1570901. doi: 10.3389/fimmu.2025.1570901. eCollection 2025.
6
Extracellular Vesicle-Based Drug Delivery Systems in Cancer Therapy.基于细胞外囊泡的癌症治疗药物递送系统
Int J Mol Sci. 2025 May 19;26(10):4835. doi: 10.3390/ijms26104835.
7
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions.癌症免疫疗法的进展:历史回顾、当前发展及未来方向。
Mol Cancer. 2025 May 7;24(1):136. doi: 10.1186/s12943-025-02305-x.
8
sEV-mediated intercellular transformation from MGAT4A to MGAT4A tumor cells via the HOTAIRM1/miR-196b-5p axis promotes apoptosis resistance in CTCL.小细胞外囊泡(sEV)通过HOTAIRM1/miR-196b-5p轴介导从MGAT4A细胞到MGAT4A肿瘤细胞的细胞间转化,促进蕈样肉芽肿(CTCL)中的细胞凋亡抗性。
Oncogene. 2025 Mar 28. doi: 10.1038/s41388-025-03356-6.
9
Dysregulated Signaling Pathways in Canine Mammary Tumor and Human Triple Negative Breast Cancer: Advances and Potential Therapeutic Targets.犬乳腺肿瘤和人类三阴性乳腺癌中失调的信号通路:进展与潜在治疗靶点
Int J Mol Sci. 2024 Dec 27;26(1):145. doi: 10.3390/ijms26010145.
10
The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD.N6-甲基腺苷写入器METTL3通过YTHDF2依赖的GSDMD转录后沉默促进乳腺癌进展。
Apoptosis. 2025 Feb;30(1-2):226-238. doi: 10.1007/s10495-024-02037-1. Epub 2024 Dec 3.